Cagrilintide

Buy Cagrilintide in Canada from Legacy Laboratories. Cagrilintide is a long-acting amylin analogue (an analogue of the pancreatic hormone that works with insulin) being researched for its effects on satiety and body-weight regulation.

What Is Cagrilintide?

Cagrilintide mimics amylin, a hormone co-secreted with insulin that signals fullness to the brain and slows the rate at which the stomach empties. Its acylated structure gives it a long half-life suitable for once-weekly research dosing.

How Cagrilintide Works

By activating amylin and calcitonin receptors, Cagrilintide is studied for promoting satiety, reducing food intake, and slowing gastric emptying — mechanisms complementary to the GLP-1 pathway.

Research & Potential Benefits

• Appetite suppression and reduced caloric intake
• Body-weight reduction in clinical research, especially combined with Semaglutide (“CagriSema”)
• Glucose and metabolic regulation

See published trials on PubMed.

Stacking Cagrilintide

Cagrilintide is most often researched in combination with Semaglutide or other GLP-1 / GIP analogues for additive appetite and weight effects.

Important Information

The information above is provided for educational and research purposes only and has not been evaluated by Health Canada or the U.S. Food & Drug Administration. Products are not intended to diagnose, treat, cure, or prevent any disease. Semaglutide and Tirzepatide are prescription medications in many jurisdictions; nothing here is medical advice. Always consult a licensed healthcare professional before beginning any new compound.